Medifast enjoyed record profits immediately after the pandemic. The emergence of GLP-1 medications has driven revenue, income, and the number of active Optavia coaches down. Management has laid ...

I n a challenging year for Medifast (NYSE:MED) Inc., the company's stock has plummeted to a 52-week low, touching down at $15.09. This significant drop reflects a stark 72.61% decrease from the ...

9,376 dieters were polled. 3,598 reported losing at least 20 pounds. Medifast losers lost big. People using the low-calorie Medifast program lost more weight than those on other diets: 20 to 43 ...

Medifast's launches OPTAVIA ASCEND — a new product line of high-protein, fiber-rich mini meals as well as a daily nutrient pack. These products are featured in a new science-backed nutrition ...

Medifast Trading Down 0.9 % Shares of NYSE:MED opened at $16.01 on Thursday. The company has a quick ratio of 2.55, a current ratio of 3.11 and a debt-to-equity ratio of 0.06. Medifast, Inc. has a ...

Medifast, Inc. MED has introduced a high-protein product line, OPTAVIA ASCEND, designed to support individuals using GLP-1 medications and those seeking help to maintain weight loss. The new line ...